Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: BDR who wrote (3565)	9/14/1999 8:52:00 PM
From: out_of_the_loop	Read Replies (1) \| Respond to of 10293

So? Do all your shorts go down in s straight line? Would you be interested in my posting Wexler's post of his short price? Maybe he covered but he recently recommended to his followers to short more ( I think it was 20%). You draw your own conclusions. I am happy even to reserve evaluation of my purchase until the end of this calendar year for nicotine gum announcements and until the end of the cold season for the success/failure of zicam & the 2 studies associated with it. You draw your own conclusions. That is what makes a market.

To: BDR who wrote (3565)	9/14/1999 9:13:00 PM
From: Mike M	Respond to of 10293

It certainly hasn't been trading in a straight line with a positive slope the entire two months. It is performing better than the S&P 500 over the same period of time...and volume increases on up days and decreases on down days indicating it is under accumulation. Not bad considering how disappointed you are that NEJM hasn't published yet....

To: BDR who wrote (3565)	9/14/1999 11:21:00 PM
From: DanZ	Respond to of 10293

Dale, GUMM has outperformed the market averages over the past few weeks although the stock has been in a trading range. There have been opportunities to trade the stock long and short, and traders are the only ones who made any money in the stock since we began talking about it on this thread. When GUMM fell to the 10 to 11 support area, I asked Bill if he was covering. He said no. Since I don't think GUMM is a good long term short, I think that was a mistake. When you trade stocks, you should buy near support and sell near resistance. Here's my prediction: If the clinical work for Zicam is accepted by the NEJM, the trading range will end abruptly. If GumTech announces a nicotine gum contract, the trading range will end abruptly. If GumTech announces a dental gum contract with a company the size of Colgate or Warner Lambert, the trading range will end abruptly. I wouldn't want to be caught short if either of these three things happens. Given my belief that it's only a matter of time before one or more of these events occur, I think it is foolish to maintain a short position in the stock. It's like playing with fire. If news comes out overnight, shorts are going to be caught with a 50% loss minimum (my guess) on the open. I'm not here to argue. I'm here to share ideas that help me and others make money. I maintain that GUMM is not a good short sale for more than a day trade. Everyone knows the risks of holding a position in it overnight. Best of luck, Dan